CFTR and autosomal dominant polycystic kidney disease: Recently, Talbi et al. showed that cAMP-activated fluid secretion through CFTR only contributed to the ADPKD pathophysiology marginally, and the deletion of CFTR was not effective in resolving the cystic phenotype in an adult ADPKD mouse model [11].